These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4001847)

  • 41. Intestinal bile acid malabsorption in cystic fibrosis.
    O'Brien S; Mulcahy H; Fenlon H; O'Broin A; Casey M; Burke A; FitzGerald MX; Hegarty JE
    Gut; 1993 Aug; 34(8):1137-41. PubMed ID: 8174969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum concentrations and excretion of bile acids in cirrhosis.
    Jönsson G; Hedenborg G; Wisén O; Norman A
    Scand J Clin Lab Invest; 1992 Nov; 52(7):599-605. PubMed ID: 1455151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis.
    Wang X; Xie G; Zhao A; Zheng X; Huang F; Wang Y; Yao C; Jia W; Liu P
    J Proteome Res; 2016 Apr; 15(4):1126-34. PubMed ID: 25964117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bile acid concentrations in systemic and portal serum in presumably normal man and in cholestatic and cirrhotic conditions.
    Lindblad L; Lundholm K; Schersten T
    Scand J Gastroenterol; 1977; 12(4):395-400. PubMed ID: 560715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholic and chenodeoxycholic acids during drainage of cholestasis in man with and without bile refeeding. Determination of serum and urinary concentrations by radioimmunoassay.
    Norlander A; Norman A; Samuelson K; Sundblad R
    Acta Chir Scand; 1983; 149(1):83-8. PubMed ID: 6132507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of a commercial enzymatic method for the determination of total serum bile acids.
    Tobiasson P; Källberg M
    Ann Clin Biochem; 1980 Nov; 17(6):301-6. PubMed ID: 6938163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Total fasting serum bile acids and beta-hexosaminidase in alcoholic liver disease.
    Joelsson B; Hultberg B; Isaksson A; Alwmark A; Gullstrand P; Bengmark S
    Clin Chim Acta; 1984 Jan; 136(2-3):203-9. PubMed ID: 6229367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis.
    Kinnman N; Lindblad A; Housset C; Buentke E; Scheynius A; Strandvik B; Hultcrantz R
    Hepatology; 2000 Aug; 32(2):334-40. PubMed ID: 10915740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Postprandial variations in serum bile acid levels in humans free of hepatic or intestinal diseases (author's transl)].
    Pageaux JF; Duperray B; Dubois M; Pacheco Y; Pacheco H; Herne N; Hauteville D
    Clin Chim Acta; 1978 Apr; 85(2):131-44. PubMed ID: 647975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum cholic and chenodeoxycholic acid conjugates and standard liver function tests in various morphological stages of alcoholic liver disease.
    Tobiasson P; Boeryd B
    Scand J Gastroenterol; 1980; 15(6):657-63. PubMed ID: 7209376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic sensitivity of fasting and postprandial serum bile acids determined by different methods.
    Mannes GA; Stellaard F; Paumgartner G
    Clin Chim Acta; 1987 Jan; 162(2):147-54. PubMed ID: 3829420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum bile acid concentrations in mild liver cirrhosis.
    Greco AV; Mingrone G
    Clin Chim Acta; 1993 Nov; 221(1-2):183-9. PubMed ID: 8149635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bile acid levels in diagnosing mild liver disease. Fasting and postcholecystokinetic values.
    Simko V; Michael S
    Arch Intern Med; 1986 Apr; 146(4):695-7. PubMed ID: 3516097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparative studies on serum bile acid concentrations before and after cholecystectomy].
    Wildgrube HJ; Weber J
    Z Gastroenterol; 1982 Aug; 20(8):459-63. PubMed ID: 7136129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver scanning and liver function in cystic fibrosis.
    Feigelson J; Pecau Y; Perez R
    Acta Paediatr Scand; 1972 May; 61(3):337-42. PubMed ID: 5021457
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum bile acid levels in children with chronic persistent hepatitis and chronic aggressive hepatitis.
    Jara P; Codoceo R; Hernanz A; Castaño C; Diaz C; Montero JL; Vázquez C
    Digestion; 1983; 27(2):81-6. PubMed ID: 6628840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct assessment of the mechanism for a raised serum bile acid level in chronic liver disease.
    de Caestecker JS; Jazrawi RP; Nisbett JA; Joseph AE; Maxwell JD; Northfield TC
    Eur J Gastroenterol Hepatol; 1995 Oct; 7(10):955-61. PubMed ID: 8590141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Determination of bile acids by radioimmunoassays (author's transl)].
    Matern S; Gerok W
    Z Gastroenterol; 1978 Mar; 16(3):162-76. PubMed ID: 636510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selectivity and sensitivity of changes in serum bile acids during induction of cirrhosis in rats.
    Azer SA; Murray M; Farrell GC; Stacey NH
    Hepatology; 1993 Nov; 18(5):1224-31. PubMed ID: 8225229
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels.
    Festi D; Capodicasa S; Sandri L; Colaiocco-Ferrante L; Staniscia T; Vitacolonna E; Vestito A; Simoni P; Mazzella G; Portincasa P; Roda E; Colecchia A
    World J Gastroenterol; 2005 Jan; 11(1):142-8. PubMed ID: 15609414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.